QRA studies

Development of a synthetic pathway & protocols that enable the manufacturing of an API for clinical supply in the required amounts and in the requested timeline. Corresponding services for non-APIs (e.g. materials, buidling blocks) are comparable.

Therapeutic Modalities:

Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

non-GMP